SCIRENT Boosts Leadership with Prof. Dr. Wilhelm Haverkamp as CMO to Enhance Drug Safety SCIRENT has appointed Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer. His expertise will significantly enhance the company's drug safety and clinical oversight initiatives.

SCIRENT Boosts Leadership with Prof. Dr. Wilhelm Haverkamp as CMO to Enhance Drug Safety #Germany #Berlin #Drug_Safety #SCIRENT #Wilhelm_Haverkamp